Joining insurance representatives, consultants, patient groups and leading drug strategist from across Canada, Chris Pryce, CEBS was hand picked to attend a National Private Payer Advisory Board meeting held September 6, 2018 in Toronto. The day consisted of presentations on pipeline drugs, market dynamics, industry research, oral oncology reimbursement and facilitated panel discussions.
Pharmaceutical manufacturers are increasingly focused on engaging thought leaders to better understand the dynamics of the Private Payer market and it was great to represent boutique advisories at this meeting.